Intas Pharmaceuticals Limited Anastrozole Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Anastrozole Export Records India — #1 Exporter, 209 Shipments, $10.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Anastrozole Exporter #1 | $10.4M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Anastrozole Exporter Profile

Indian Pharmaceutical Exporter · #1 for Anastrozole · $10.4M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Anastrozole with $10.4M in export value and 209 verified shipments. Intas Pharmaceuticals Limited holds a 9.4% market share in Anastrozole exports across 13 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Anastrozole Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Anastrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Anastrozole?

Country	Value	Shipments	Share
UNITED STATES	$2.0M	99	76.3%
UNITED KINGDOM	$246.6K	27	9.5%
SOUTH AFRICA	$90.7K	9	3.5%
CANADA	$85.0K	10	3.3%

Who Are the Top Buyers of Anastrozole from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$1.2M	54
EVERSANA LIFE SCIENCES SERVICES LLC	UNITED STATES	$498.4K	23
ACCORD UK	UNITED KINGDOM	$246.6K	20
TO THE ORDER	MALTA	$172.6K	24
ACCORD HEALTHCARE INC.	CANADA	$75.9K	5
ALPHAPHARM PTY LIMITED	AUSTRALIA	$68.7K	9
EVERSANA LIFE SCIENCES SERVICESLLC	UNITED STATES	$58.9K	7
ACCORD HEALTHCARE C/O QESTMED (PTY)	SOUTH AFRICA	$52.0K	2
SIVEM PHARMACEUTICALS	UNITED STATES	$39.6K	2
TO HE ORDER	UNITED STATES	$35.6K	3

Intas Pharmaceuticals Limited supplies Anastrozole to 31 buyers globally. The largest buyer is EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES) and ACCORD UK (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Anastrozole Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHR DRUGS&MEDI ANASTROZOLE TABLETS 1 MG	$410.3K	14
PHARMA DRUGS & MEDI ANASTROZOLE TABLETS	$179.5K	14
PHR DRUGS & MEDI ANASTROZOLE TABLETS 1 M	$158.1K	4
PHARMA DRUGS MEDI ANASTROZOLE TABLETS 1 MG AS PER INVOICE	$144.4K	9
PHR DRUGS MEDI ANASTROZOLE TABLETS 1 MG EACH FILM COATED TABLET CONTAINS ANASTROZOLE USP 1MG AS PER INVOICE	$138.0K	4
PHARMA DRUGS MEDI ANASTROZOLE 1MG 2X14T G1 ACCORD UK AS PER INVOICE	$126.6K	13
PHARMA DRUGS & MEDI ANASTROZOLE TABLETS 1 MG AS PER INVOICE	$103.4K	6
PHARMA DRUGS & MEDI ANASTROZOLE TABLETS1 MG AS PER INVOICE	$96.8K	9
PHARMACEUTICAL DRUGS AND MEDICINE ANASTROZOLE TABLETS 1 MG AS PER INVOICE	$93.2K	8
PHA.DRU & MEDI, ANASTROZOLE TABLETS 1 MG	$84.9K	2

Intas Pharmaceuticals Limited exports 80 distinct Anastrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHR DRUGS&MEDI ANASTROZOLE TABLETS 1 MG with 14 shipments worth $410.3K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Anastrozole Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$10.4M	209	13	$50.0K
2	ZYDUS LIFESCIENCES LIMITED	$3.6M	111	3	$32.4K
3	EUGIA PHARMA SPECIALITIES LIMITED	$3.5M	116	6	$30.4K

Intas Pharmaceuticals Limited ranks #1 among 158 Indian Anastrozole exporters. Average shipment value of $50.0K compared to the market average of $163.1K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Anastrozole Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	465	20.8%
SAHAR AIR	391	17.5%
DELHI AIR CARGO ACC (INDEL4)	280	12.5%
DELHI AIR	167	7.5%
MUNDRA SEA	90	4.0%
Bombay Air	86	3.8%
HYDERABAD AIR	75	3.4%
MUNDRA SEA (INMUN1)	70	3.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Anastrozole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Anastrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 212 individual customs records matching Intas Pharmaceuticals Limited exporting Anastrozole, covering 80 formulations to 13 countries via 31 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 99+ countries, 387+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Anastrozole

Anastrozole

Intas Pharmaceuticals Limited — Anastrozole Exporter Profile

Intas Pharmaceuticals Limited — Anastrozole Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Anastrozole?

Who Are the Top Buyers of Anastrozole from Intas Pharmaceuticals Limited?

What Is India's Total Anastrozole Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Anastrozole Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Anastrozole Exporters?

What Anastrozole Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Anastrozole to Key Markets

United States — FDA

United Kingdom — MHRA

South Africa — SAHPRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Anastrozole Exporters?

Which Indian Ports Ship Anastrozole Exports?

What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?

Anastrozole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Anastrozole Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Anastrozole Export Data from Intas Pharmaceuticals Limited

Anastrozole Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source